— CLINICAL PERFORMANCE & VALIDATION

Evidence first.
Product by product.

Performance data appears only where an uploaded controlled IFU supports the named product, sample population and comparator. Values are never extrapolated across the portfolio.

— IFU-SOURCED CLINICAL PERFORMANCE

VISION HIV I-II Ab Rapid Test Kit

Clinical laboratory blood specimens; values reported in the controlled Rev.04 IFU.

99.34%Sensitivity
99.4%Specificity
318Evaluated specimens
ELISAComparator method

Values apply only to the named product and study population described in the source IFU. They must not be extrapolated to other products, specimen types or markets.

Open the controlled source IFU ↗

A growing controlled evidence archive.

The first IFU-sourced product records are now published with sensitivity, specificity, evaluated specimen count and comparator method. Additional products will appear as their controlled source files are uploaded and reviewed.

Search the IFU and document hub →
HomeWhatsApp